A prospective cohort of men with localized prostate cancer on active surveillance protocol in Hong Kong, China: what did we learn?

active surveillance cohort localized prostate cancer pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access yes pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement no pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes pmc-license-ref CC BY-NC-SA INTRODUCTION There was an increasing trend of new cases registered as prostate cancer (PCa) in Hong Kong (China), from 1484 cases in 2009 to 2315 cases in 2020. 1 In 2020, PCa was the third most common male cancer being diagnosed in Hong Kong (China). 2 Radical prostatectomy (RP) and radiotherapy (RT) are the traditional treatment choices f

also in 63,971 other papers